EDUCATION

Undergraduate Degree

  • North Carolina State University , 1986 , Raleigh , NC

Medical School

  • University of North Carolina , 1991 , Chapel Hill , NC

Internship

  • Boston Children's Hospital , 1992 , Boston , MA

Residency

  • Boston Children's Hospital , 1994 , Boston , MA

Fellowship

  • Boston Children's Hospital , 1998 , Boston , MA

Graduate Degree

  • Harvard Medical School , 1998 , Boston , MA

Philosophy of Care

Helping adolescents and their families is a pleasure and privilege. I use a multidisciplinary approach to identify needs and help a teen to be their "best self." Special interests include reproductive endocrinology and bone health. I also enjoy working with adolescent athletes, including helping them through injuries and keeping them healthy. It is rewarding to help them get back "in the game!"

PROFESSIONAL HISTORY

Catherine M. Gordon, MD, MS is an adolescent medicine specialist and pediatric endocrinologist by training, and is Chief of the Division of Adolescent/Young Adult Medicine at Boston Children's Hospital. She is also an attending physician in the Division of Endocrinology, Director of the Boston Children’s DXA Center and Co-Director of the Center for Young Women’s Health. Special interests include menstrual disorders, delayed puberty, primary ovarian insufficiency, eating disorders, and pediatric and adolescent bone health. Dr. Gordon sees patients in Boston and Lexington.

Dr. Gordon's research, which has been funded by the National Institutes of Health, Department of Defense, and private foundations, focuses on how nutrition, activity and sex hormones influence bone health during childhood and adolescence. She is a member of the Sub-board on Adolescent Medicine for the American Board of Pediatrics, the Executive Committee (Board of Directors) for the Thrasher Research Fund, the Council for the Eunice Kennedy Shriver National Institute on Child Health and Human Development (NICHD), and the American Pediatric Society Council. She is a member of several editorial boards for medical journals and serves as an associate editor for the journal, Bone, and the Journal of Adolescent Health. Lastly, she has a strong interest in mentoring early clinical investigators, and has directed hospital-based programs to help junior faculty launch careers in clinical and translational research.

CERTIFICATIONS

  • American Board of Pediatrics, Adolescent Medicine
  • American Board of Pediatrics, Pediatric Endocrinology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Is Ovarian Reserve Impacted in Anorexia Nervosa? J Pediatr Adolesc Gynecol. 2020 Dec 03. View abstract
  2. The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis. J Clin Endocrinol Metab. 2020 Dec 01. View abstract
  3. Racism and social injustice as determinants of child health: the American Pediatric Society Issue of the Year. Pediatr Res. 2020 11; 88(5):691-693. View abstract
  4. The american pediatric society and society for pediatric research joint statement against racism and social injustice. Pediatr Res. 2020 Sep 03. View abstract
  5. Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk. J Adolesc Health. 2021 Mar; 68(3):517-522. View abstract
  6. Lessons Learned in Caring for Adolescents With Eating Disorders: The Singapore Experience. J Adolesc Health. 2020 Jul; 67(1):5-6. View abstract
  7. Correlation of Functional Magnetic Resonance Imaging Response to Visual Food Stimuli With Clinical Measures in Adolescents With Restrictive Eating Disorders. J Adolesc Health. 2020 Aug; 67(2):209-217. View abstract
  8. DXA in Children and Adolescents. J Clin Densitom. 2021 Jan-Mar; 24(1):28-35. View abstract
  9. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States). Environ Health Perspect. 2019 08; 127(8):87006. View abstract
  10. BMI, Waist Circumference, and Risk of Incident Vertebral Fracture in Women. Obesity (Silver Spring). 2019 09; 27(9):1513-1519. View abstract
  11. The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position. J Clin Densitom. 2019 Oct - Dec; 22(4):567-589. View abstract
  12. Impact of Adrenal Hormone Supplementation on Bone Geometry in Growing Teens With Anorexia Nervosa. J Adolesc Health. 2019 10; 65(4):462-468. View abstract
  13. Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome. Bone. 2019 08; 125:103-111. View abstract
  14. Long-term Skeletal Consequences of Anorexia Nervosa: A "Wake up Call". J Adolesc Health. 2019 03; 64(3):283-285. View abstract
  15. Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review. Bone. 2019 04; 121:60-67. View abstract
  16. Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis. AIDS Res Hum Retroviruses. 2019 02; 35(2):123-128. View abstract
  17. Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone. Antivir Ther. 2018; 23(7):623-628. View abstract
  18. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States. J Pediatr Adolesc Gynecol. 2018 Dec; 31(6):605-609. View abstract
  19. Vitamin D and associated perinatal-neonatal outcomes among extremely low-birth-weight infants. J Perinatol. 2018 10; 38(10):1318-1323. View abstract
  20. Forty years of IVF. Fertil Steril. 2018 07 15; 110(2):185-324.e5. View abstract
  21. Single Ultra-High-Dose Cholecalciferol to Prevent Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 09; 24(9):1856-1860. View abstract
  22. Proton Pump Inhibitor Use, H2-Receptor Antagonist Use, and Risk of Incident Clinical Vertebral Fracture in Women. Calcif Tissue Int. 2018 10; 103(4):380-387. View abstract
  23. Bone fragility in Turner syndrome: Fracture prevalence and risk factors determined by a national patient survey. Clin Endocrinol (Oxf). 2018 07; 89(1):46-55. View abstract
  24. Connect the Dots-May 2018. Obstet Gynecol. 2018 05; 131(5):930-931. View abstract
  25. Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis. J Pediatr Adolesc Gynecol. 2018 Aug; 31(4):376-381. View abstract
  26. Magnetic resonance imaging and spectroscopy evidence of efficacy for adrenal and gonadal hormone replacement therapy in anorexia nervosa. Bone. 2018 05; 110:335-342. View abstract
  27. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clin Infect Dis. 2018 01 06; 66(2):220-228. View abstract
  28. Pubertal Progression in Female Adolescents with Progeria. J Pediatr Adolesc Gynecol. 2018 Jun; 31(3):238-241. View abstract
  29. Impact of Three Doses of Vitamin D3 on Serum 25(OH)D Deficiency and Insufficiency in At-Risk Schoolchildren. J Clin Endocrinol Metab. 2017 12 01; 102(12):4496-4505. View abstract
  30. Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density. J Clin Endocrinol Metab. 2017 12 01; 102(12):4568-4577. View abstract
  31. Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis. J Clin Densitom. 2018 Jan - Mar; 21(1):3-21. View abstract
  32. Investigation of the C-3-epi-25(OH)D3 of 25-hydroxyvitamin D3 in urban schoolchildren. Appl Physiol Nutr Metab. 2018 Mar; 43(3):259-265. View abstract
  33. Evaluation and Management of Primary Ovarian Insufficiency in Adolescents and Young Adults. J Pediatr Adolesc Gynecol. 2018 Feb; 31(1):13-18. View abstract
  34. Bone Mineralization and Fracture Risk Assessment in the Pediatric Population. J Clin Densitom. 2017 Jul - Sep; 20(3):389-396. View abstract
  35. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 05 01; 102(5):1413-1439. View abstract
  36. Bone marrow fat content in 70 adolescent girls with anorexia nervosa: Magnetic resonance imaging and magnetic resonance spectroscopy assessment. Pediatr Radiol. 2017 Jul; 47(8):952-962. View abstract
  37. Use of dual energy X-ray absorptiometry in pediatric patients. Bone. 2017 Nov; 104:84-90. View abstract
  38. Use of yoga in outpatient eating disorder treatment: a pilot study. J Eat Disord. 2016; 4:38. View abstract
  39. Effect of Exercise and Antidepressants on Skeletal Outcomes in Adolescent Girls With Anorexia Nervosa. J Adolesc Health. 2017 Feb; 60(2):229-232. View abstract
  40. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis. Clin Infect Dis. 2017 Feb 01; 64(3):317-325. View abstract
  41. The Determinants of Peak Bone Mass. J Pediatr. 2017 01; 180:261-269. View abstract
  42. Bone Densitometry in Children and Adolescents. Pediatrics. 2016 10; 138(4). View abstract
  43. Diuretic Use and Risk of Vertebral Fracture in Women. Am J Med. 2016 Dec; 129(12):1299-1306. View abstract
  44. Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome. Circulation. 2016 Jul 12; 134(2):114-25. View abstract
  45. Restrictive Eating Disorders and Skeletal Health in Adolescent Girls and Young Women. Calcif Tissue Int. 2017 05; 100(5):449-460. View abstract
  46. Best Practices for Dual-Energy X-ray Absorptiometry Measurement and Reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom. 2016 Apr-Jun; 19(2):127-40. View abstract
  47. Sun-Exposed Skin Color Is Associated with Changes in Serum 25-Hydroxyvitamin D in Racially/Ethnically Diverse Children. J Nutr. 2016 04; 146(4):751-7. View abstract
  48. The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial. J Pediatr Adolesc Gynecol. 2017 Apr; 30(2):215-222. View abstract
  49. Fractures Among Inpatients in a Pediatric Hospital. Hosp Pediatr. 2016 Mar; 6(3):143-50. View abstract
  50. Sugar-Sweetened Beverage Intake Is Positively Associated with Baseline Triglyceride Concentrations, and Changes in Intake Are Inversely Associated with Changes in HDL Cholesterol over 12 Months in a Multi-Ethnic Sample of Children. J Nutr. 2015 Oct; 145(10):2389-95. View abstract
  51. Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial. Obstet Gynecol. 2015 Sep; 126(3):617-627. View abstract
  52. Fractures Related to Metabolic Bone Disease in Children with Congenital Heart Disease. Congenit Heart Dis. 2016 Jan-Feb; 11(1):80-6. View abstract
  53. Update on primary ovarian insufficiency in adolescents. Curr Opin Pediatr. 2015 Aug; 27(4):511-9. View abstract
  54. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients. J Cyst Fibros. 2016 Mar; 15(2):234-41. View abstract
  55. The Weight of Vitamin D on Obesity Outcomes: What Do We Know? J Adolesc Health. 2015 Jul; 57(1):1-2. View abstract
  56. Spinal Bone Texture Assessed by Trabecular Bone Score in Adolescent Girls With Anorexia Nervosa. J Clin Endocrinol Metab. 2015 Sep; 100(9):3436-42. View abstract
  57. Skeletal complications of eating disorders. Metabolism. 2015 Sep; 64(9):943-51. View abstract
  58. Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia. Clin Med Insights Oncol. 2015; 9:51-60. View abstract
  59. Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period. J Cyst Fibros. 2015 Jul; 14(4):526-32. View abstract
  60. Leadership in adolescent health: developing the next generation of maternal child health leaders through mentorship. Matern Child Health J. 2015 Feb; 19(2):308-13. View abstract
  61. Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation. Pediatr Blood Cancer. 2015 Apr; 62(4):687-92. View abstract
  62. Abdominal obesity: what does it mean in an adolescent? J Clin Densitom. 2015 Jan-Mar; 18(1):3-4. View abstract
  63. Recruitment and retention of urban schoolchildren into a randomized double-blind vitamin D supplementation trial. Clin Trials. 2015 Feb; 12(1):45-53. View abstract
  64. Underweight, overweight, and pediatric bone fragility: impact and management. Curr Osteoporos Rep. 2014 Sep; 12(3):319-28. View abstract
  65. MR Imaging in a case of severe anorexia nervosa: the 'flip-flop' effect. Pediatr Radiol. 2015 Apr; 45(4):617-20. View abstract
  66. Vitamin D: Recent Recommendations and Discoveries. Adolesc Med State Art Rev. 2014 Aug; 25(2):239-50. View abstract
  67. Maintenance of optimal vitamin D status in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing two regimens. J Clin Endocrinol Metab. 2014 Sep; 99(9):3408-17. View abstract
  68. Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis. J Clin Endocrinol Metab. 2014 Sep; 99(9):3399-407. View abstract
  69. Run, jump, and be merry: how much exercise is needed for building young bones? J Bone Miner Res. 2014 Jun; 29(6):1322-4. View abstract
  70. Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children. J Pediatr Gastroenterol Nutr. 2014 Jun; 58(6):709-14. View abstract
  71. Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions. J Clin Densitom. 2014 Apr-Jun; 17(2):225-42. View abstract
  72. 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom. 2014 Apr-Jun; 17(2):219-24. View abstract
  73. Percentage body fat by dual-energy X-ray absorptiometry is associated with menstrual recovery in adolescents with anorexia nervosa. J Adolesc Health. 2014 Jun; 54(6):739-41. View abstract
  74. Low bone density during childhood: what does it predict? J Pediatr. 2014 Jun; 164(6):1252-4. View abstract
  75. Microdosing of scopolamine as a "cognitive stress test": rationale and test of a very low dose in an at-risk cohort of older adults. Alzheimers Dement. 2014 Mar; 10(2):262-7. View abstract
  76. Outcome of overt stroke in sickle cell anaemia, a single institution's experience. Br J Haematol. 2014 Jun; 165(5):707-13. View abstract
  77. Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate. Antivir Ther. 2014; 19(6):613-8. View abstract
  78. Vitamin D status in children with cystic fibrosis. Associations with inflammation and bacterial colonization. Ann Am Thorac Soc. 2014 Feb; 11(2):205-10. View abstract
  79. Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa? J Bone Miner Res. 2014 Jan; 29(1):151-7. View abstract
  80. Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates. Inflamm Bowel Dis. 2013 Dec; 19(13):2919-26. View abstract
  81. Breastfeeding initiation in teen mothers. J Pediatr. 2013 Nov; 163(5):1235-9. View abstract
  82. Exercise and bone: where do we stand? Metabolism. 2013 Dec; 62(12):1714-7. View abstract
  83. The authors reply. J Adolesc Health. 2013 Oct; 53(4):548-9. View abstract
  84. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 2013 Nov; 57(11):5619-28. View abstract
  85. The use and effectiveness of complementary and alternative medicine for pain in sickle cell anemia. Complement Ther Clin Pract. 2013 Nov; 19(4):184-7. View abstract
  86. 50 years ago in the Journal of Pediatrics: Neonatal fibrous dysplasia. Turner AF, Mikity VG, Meyers HI. J Pediatr 1963;62:936-7. J Pediatr. 2013 Jun; 162(6):1119. View abstract
  87. Vertebral fracture assessment in adolescents and young women with anorexia nervosa: a case series. J Clin Densitom. 2014 Jan-Mar; 17(1):207-11. View abstract
  88. Factors associated with low bone density in patients referred for assessment of bone health. Int J Pediatr Endocrinol. 2013 Feb 06; 2013(1):4. View abstract
  89. 50 years ago in the Journal of Pediatrics: congenital adrenal hyperplasia with defect in electrolyte metabolism: observations before the onset of symptoms. J Pediatr. 2013 Jan; 162(1):165. View abstract
  90. Measures of the forearm via a portable device: ready for prime time? J Clin Densitom. 2013 Jan-Mar; 16(1):125-6. View abstract
  91. A randomized clinical trial of vitamin D supplementation in healthy adolescents. J Adolesc Health. 2013 May; 52(5):592-8. View abstract
  92. The truth about vitamin D and adolescent skeletal health. Adolesc Med State Art Rev. 2012 Dec; 23(3):457-70. View abstract
  93. The male reproductive system in classic galactosemia: cryptorchidism and low semen volume. J Inherit Metab Dis. 2013 Sep; 36(5):779-86. View abstract
  94. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2012 Oct 09; 109(41):16666-71. View abstract
  95. Pediatric osteoporosis: where are we now? J Pediatr. 2012 Dec; 161(6):983-90. View abstract
  96. Fractures in hospitalized children. Metabolism. 2013 Mar; 62(3):315-25. View abstract
  97. Vitamin D deficiency in critically ill children. Pediatrics. 2012 Sep; 130(3):421-8. View abstract
  98. Fractures: abuse or rickets? Radiology. 2012 Aug; 264(2):615; author reply 615-7. View abstract
  99. A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome. Pediatr Radiol. 2012 Sep; 42(9):1089-98. View abstract
  100. Vitamin d, calcium, and dairy intakes and stress fractures among female adolescents. Arch Pediatr Adolesc Med. 2012 Jul 01; 166(7):595-600. View abstract
  101. Synovial sarcoma leading to a paraesophageal abscess in a child. Am J Case Rep. 2012; 13:128-32. View abstract
  102. Consequences of brand switches during the course of pediatric growth hormone treatment. Endocr Pract. 2012 May-Jun; 18(3):307-16. View abstract
  103. Vitamin D status in children with chronic kidney disease. Pediatr Nephrol. 2012 Aug; 27(8):1341-50. View abstract
  104. Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. J Clin Endocrinol Metab. 2012 Jun; 97(6):2134-42. View abstract
  105. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012 Apr; 97(4):1153-8. View abstract
  106. Dietary calcium and body weight: what's the "skinny"? Metabolism. 2012 Feb; 61(2):137-9. View abstract
  107. The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism. 2012 Jul; 61(7):1010-20. View abstract
  108. Approach to the adolescent requesting contraception. J Clin Endocrinol Metab. 2012 Jan; 97(1):9-15. View abstract
  109. Effect of titrated parenteral nutrition on body composition after allogeneic hematopoietic stem cell transplantation in children: a double-blind, randomized, multicenter trial. Am J Clin Nutr. 2012 Feb; 95(2):342-51. View abstract
  110. Advance provision of emergency contraception in an urban pediatric emergency department. J Pediatr Adolesc Gynecol. 2011 Dec; 24(6):392-6. View abstract
  111. Rachitic changes, demineralization, and fracture risk in healthy infants and toddlers with vitamin D deficiency. Radiology. 2012 Jan; 262(1):234-41. View abstract
  112. Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2012 Feb; 25(1):23-6. View abstract
  113. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011 Oct; 53(4):361-4. View abstract
  114. Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshop. J Bone Miner Res. 2011 Nov; 26(11):2565-78. View abstract
  115. Bone density in post-pubertal adolescent survivors of childhood brain tumors. Pediatr Blood Cancer. 2012 Jun; 58(6):959-63. View abstract
  116. State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). Int J Pediatr Endocrinol. 2011 Aug 26; 2011:9. View abstract
  117. The exposure of fetuses and children to endocrine disrupting chemicals: a European Society for Paediatric Endocrinology (ESPE) and Pediatric Endocrine Society (PES) call to action statement. J Clin Endocrinol Metab. 2011 Oct; 96(10):3056-8. View abstract
  118. The adult galactosemic phenotype. J Inherit Metab Dis. 2012 Mar; 35(2):279-86. View abstract
  119. Leptin and the skeleton-where is the fat? Metabolism. 2011 Sep; 60(9):1203-6. View abstract
  120. The Hormone Foundation’s: Patient guide to vitamin D deficiency. J Clin Endocrinol Metab. 2011 Jul; 96(7):1-2. View abstract
  121. Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011 Jul; 53(1):11-25. View abstract
  122. Hutchinson-Gilford progeria is a skeletal dysplasia. J Bone Miner Res. 2011 Jul; 26(7):1670-9. View abstract
  123. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul; 96(7):1911-30. View abstract
  124. Bioavailability of vitamin D in malnourished adolescents with anorexia nervosa. J Clin Endocrinol Metab. 2011 Aug; 96(8):2575-80. View abstract
  125. Vitamin D deficiency in adolescents: what can obesity teach us? J Adolesc Health. 2011 May; 48(5):427-8. View abstract
  126. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. Am J Gastroenterol. 2011 Aug; 106(8):1527-43. View abstract
  127. Prospective study of physical activity and risk of developing a stress fracture among preadolescent and adolescent girls. Arch Pediatr Adolesc Med. 2011 Aug; 165(8):723-8. View abstract
  128. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011 Feb; 127(2):347-57. View abstract
  129. Pediatrics: Supplements: when will vitamin D have its day in the sun? Nat Rev Endocrinol. 2010 Oct; 6(10):539-40. View abstract
  130. Hormone replacement therapy and the adolescent. Curr Opin Obstet Gynecol. 2010 Oct; 22(5):363-8. View abstract
  131. An inflection point of serum 25-hydroxyvitamin D for maximal suppression of parathyroid hormone is not evident from multi-site pooled data in children and adolescents. J Nutr. 2010 Nov; 140(11):1983-8. View abstract
  132. Malnutrition and hemodynamic status in adolescents hospitalized for anorexia nervosa. Arch Pediatr Adolesc Med. 2010 Aug; 164(8):706-13. View abstract
  133. Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med. 2010 Jul 22; 363(4):365-71. View abstract
  134. Salivary progesterone levels before menarche: a prospective study of adolescent girls. J Clin Endocrinol Metab. 2010 Jul; 95(7):3507-11. View abstract
  135. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045. AIDS. 2010 Mar 13; 24(5):687-96. View abstract
  136. Bone marrow changes in adolescent girls with anorexia nervosa. J Bone Miner Res. 2010 Feb; 25(2):298-304. View abstract
  137. A multi-center, randomized, controlled trial of parenteral nutrition titrated to resting energy expenditure in children undergoing hematopoietic stem cell transplantation ("PNTREE"): rationale and design. Contemp Clin Trials. 2010 Mar; 31(2):157-64. View abstract
  138. Vitamin D and adolescents: what do we know? Curr Opin Pediatr. 2009 Aug; 21(4):465-71. View abstract
  139. Prevalence of transient hyperphosphatasemia among healthy infants and toddlers. Pediatrics. 2009 Aug; 124(2):703-9. View abstract
  140. Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol. 2010 Jan; 25(1):37-47. View abstract
  141. Early pubertal development in Chinese girls. Pediatrics. 2009 Aug; 124(2):799-801. View abstract
  142. The effect of bed rest on bone turnover in young women hospitalized for anorexia nervosa: a pilot study. J Clin Endocrinol Metab. 2009 May; 94(5):1650-5. View abstract
  143. Boning up: exploring bone structure and strength in children with Crohn's disease. Gastroenterology. 2009 Jan; 136(1):35-9. View abstract
  144. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone. 2008 Dec; 43(6):1115-21. View abstract
  145. Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int. 2008 Oct; 19(10):1369-78. View abstract
  146. Special report on the 2007 Pediatric Position Development Conference of the International Society for Clinical Densitometry. South Med J. 2008 Jul; 101(7):740-3. View abstract
  147. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med. 2008 Jun; 162(6):505-12. View abstract
  148. Rickets in an otherwise healthy 11-month-old. Clin Pediatr (Phila). 2008 May; 47(4):409-12. View abstract
  149. Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab. 2008 Jul; 93(7):2716-21. View abstract
  150. Prevalence and predictors of abnormal liver enzymes in young women with anorexia nervosa. J Pediatr. 2008 Aug; 153(2):247-53. View abstract
  151. Irregular menses linked to vomiting in a nonclinical sample: findings from the National Eating Disorders Screening Program in high schools. J Adolesc Health. 2008 May; 42(5):450-7. View abstract
  152. Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord. 2008 Jun; 9(2):161-70. View abstract
  153. The menstrual cycle and adolescent health. Preface. Ann N Y Acad Sci. 2008; 1135:xi-xii. View abstract
  154. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom. 2008 Jan-Mar; 11(1):43-58. View abstract
  155. Hormone replacement therapy for the adolescent patient. Ann N Y Acad Sci. 2008; 1135:204-11. View abstract
  156. Oral health and bone density in adolescents and young women with anorexia nervosa. J Clin Pediatr Dent. 2008; 33(2):87-92. View abstract
  157. Passion for participatory research on the menstrual cycle. Ann N Y Acad Sci. 2008; 1135:306-8. View abstract
  158. Reflections on future research in adolescent reproductive health. Ann N Y Acad Sci. 2008; 1135:296-305. View abstract
  159. Nutrient status of adults with cystic fibrosis. J Am Diet Assoc. 2007 Dec; 107(12):2114-9. View abstract
  160. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporos Int. 2008 Mar; 19(3):289-94. View abstract
  161. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. J Pediatr Adolesc Gynecol. 2007 Oct; 20(5):293-7. View abstract
  162. Polycystic ovary syndrome update in adolescence. Curr Opin Pediatr. 2007 Aug; 19(4):389-97. View abstract
  163. Family history predicts stress fracture in active female adolescents. Pediatrics. 2007 Aug; 120(2):e364-72. View abstract
  164. Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. 2007 Apr; 20(2):67-72. View abstract
  165. Skeletal measurements by quantitative ultrasound in adolescents and young women with anorexia nervosa. J Pediatr. 2007 Mar; 150(3):286-90, 290.e1. View abstract
  166. Bone mineral status in children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2007 Feb; 20(2):227-35. View abstract
  167. Optimizing aerosol gene delivery and expression in the ovine lung. Mol Ther. 2007 Feb; 15(2):348-54. View abstract
  168. Bone cross-sectional geometry in adolescents and young women with anorexia nervosa: a hip structural analysis study. Osteoporos Int. 2007 Jun; 18(6):797-804. View abstract
  169. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006 Dec; 12(12):1162-74. View abstract
  170. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006 Nov; 118(5):1950-61. View abstract
  171. Adolescent bone health. Arch Pediatr Adolesc Med. 2006 Oct; 160(10):1026-32. View abstract
  172. Bone health in adolescents. Adolesc Med Clin. 2006 Oct; 17(3):639-52; abstract xi. View abstract
  173. Effects of nutrition, puberty, and gender on bone ultrasound measurements in adolescents and young adults. J Adolesc Health. 2006 Dec; 39(6):828-34. View abstract
  174. Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study. J Pediatr Endocrinol Metab. 2006 Jun; 19(6):821-30. View abstract
  175. Bone loss in children with Crohn disease: Evidence of "osteoimmune" alterations. J Pediatr. 2006 Apr; 148(4):429-32. View abstract
  176. Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis. Osteoporos Int. 2006; 17(5):783-90. View abstract
  177. Influence of bone density results on adolescents with anorexia nervosa. Int J Eat Disord. 2005 Apr; 37(3):250-5. View abstract
  178. Correlates of stress fractures among preadolescent and adolescent girls. Pediatrics. 2005 Apr; 115(4):e399-406. View abstract
  179. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr. 2005 Mar-Apr; 5(2):107-11. View abstract
  180. Bone health in children and adolescents: a symposium at the annual meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003. Curr Probl Pediatr Adolesc Health Care. 2004 Jul; 34(6):226-42. View abstract
  181. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004 Jun; 158(6):531-7. View abstract
  182. Preventing 3 million premature deaths and helping 5 million smokers quit: a national action plan for tobacco cessation. Am J Public Health. 2004 Feb; 94(2):205-10. View abstract
  183. Clinical uses and misuses of dehydroepiandrosterone. Curr Opin Pharmacol. 2003 Dec; 3(6):635-41. View abstract
  184. Amenorrhea and bone health in adolescents and young women. Curr Opin Obstet Gynecol. 2003 Oct; 15(5):377-84. View abstract
  185. Normal bone accretion and effects of nutritional disorders in childhood. J Womens Health (Larchmt). 2003 Mar; 12(2):137-43. View abstract
  186. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol. 2003 Feb; 16(1):33-7. View abstract
  187. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab. 2002 Nov; 87(11):4935-41. View abstract
  188. Adolescent androgen abnormalities. Curr Opin Obstet Gynecol. 2002 Oct; 14(5):445-51. View abstract
  189. Physiologic regulators of bone turnover in young women with anorexia nervosa. J Pediatr. 2002 Jul; 141(1):64-70. View abstract
  190. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2002 Jun; 156(6):556-60. View abstract
  191. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002 Mar; 87(3):1017-23. View abstract
  192. Adrenal and gonadal steroids inhibit IL-6 secretion by human marrow cells. Cytokine. 2001 Dec 07; 16(5):178-86. View abstract
  193. Neural substrates of anorexia nervosa: a behavioral challenge study with positron emission tomography. J Pediatr. 2001 Jul; 139(1):51-7. View abstract
  194. Bone density issues in the adolescent gynecology patient. J Pediatr Adolesc Gynecol. 2000 Nov; 13(4):157-61. View abstract
  195. Endocrinologic and psychological effects of short-term dexamethasone in anorexia nervosa. Eat Weight Disord. 2000 Sep; 5(3):175-82. View abstract
  196. Neuroanatomy of human appetitive function: A positron emission tomography investigation. Int J Eat Disord. 2000 Mar; 27(2):163-71. View abstract
  197. DHEA and the skeleton (through the ages). Endocrine. 1999 Aug; 11(1):1-11. View abstract
  198. Menstrual disorders in adolescents. Excess androgens and the polycystic ovary syndrome. Pediatr Clin North Am. 1999 Jun; 46(3):519-43. View abstract
  199. Is there an increased clinical severity of patients with eating disorders under managed care? J Adolesc Health. 1999 Jun; 24(6):422-6. View abstract
  200. Polycystic ovary syndrome. Adolesc Med. 1999 Jun; 10(2):321-36. View abstract
  201. Understanding HIV-related risk among persons with a severe and persistent mental illness: insights from qualitative inquiry. J Nerv Ment Dis. 1999 Apr; 187(4):208-16. View abstract
  202. Changes in bone turnover markers and menstrual function after short-term oral DHEA in young women with anorexia nervosa. J Bone Miner Res. 1999 Jan; 14(1):136-45. View abstract
  203. "Add-back" therapy for endometriosis in adolescents. J Reprod Med. 1998 Mar; 43(3):164-72. View abstract
  204. Four cases of mucosal neuroma syndrome: multiple endocrine neoplasm 2B or not 2B? J Clin Endocrinol Metab. 1998 Jan; 83(1):17-20. View abstract
  205. Primary hypothyroidism presenting as severe vaginal bleeding in a prepubertal girl. J Pediatr Adolesc Gynecol. 1997 Feb; 10(1):35-8. View abstract
  206. Changing needs of the patient with diabetes mellitus during the teenage years. Curr Opin Pediatr. 1996 Aug; 8(4):319-27. View abstract
  207. Topical iodine and neonatal hypothyroidism. Arch Pediatr Adolesc Med. 1995 Dec; 149(12):1336-9. View abstract